SCHEMBL3110258

SCHEMBL3110258

CC/C=C\CCC1(C)CCC(=O)O1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 3/20 0.34
SIRT2 Q8IXJ6 1/20 0.31
ALOX5 P09917 2/20 0.30
PTPN1 P18031 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532400 1.00 PRKCA (0.34) PRKCASIRT2ALOX5PTPN1
SCHEMBL3110275 1.00 PRKCA (0.34) PRKCASIRT2ALOX5PTPN1
SCHEMBL7666454 0.81 PTPN1 (0.34) PTPN1
SCHEMBL3661073 0.78 SIRT2 (0.39) PRKCASIRT2
SCHEMBL7744116 0.77 ALOX5 (0.39) ALOX5
SCHEMBL7129843 0.77 ALOX5 (0.39) ALOX5
SCHEMBL7129846 0.77 ALOX5 (0.39) ALOX5
SCHEMBL11220241 0.74 PRKCA (0.43) PRKCASIRT2PTPN1
SCHEMBL5670125 0.74
SCHEMBL12951363 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 EP claimed
WO-2024156688-A1 BIODEGRADABLE PERFUME COMPOSITION GIVAUDAN SA (CH) 2024-08-02 WO claimed
EP-4407019-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2024-07-31 EP claimed
US-20240173230-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2024-05-30 US claimed
EP-4319715-A1 FRAGRANCE COMPOSITION Givaudan SA (CH) 2024-02-14 EP claimed
CN-116903980-A High-wear-resistance film material based on glass fiber and preparation process thereof 上海惊叹化学有限公司 2023-10-20 CN claimed
US-20220363976-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES CHAMPIONX LLC 2022-11-17 US claimed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 WO claimed
CN-106632162-B The synthetic method of 4 methyl 4 (cis 3 hexenyl) 4 butyrolactone 北京安胜瑞力科技有限公司 2017-12-12 CN claimed
CN-106632162-A Synthetic method of 4-methyl-4-(cis-3-hexenyl)-4-butyrolactone 北京安胜瑞力科技有限公司 2017-05-10 CN claimed
CN-1874749-A Fragrance composition comprising residual accords PROCTER & GAMBLE (US) 2006-12-06 CN claimed
US-7105628-B2 Compositions for golf equipment ACUSHNET COMPANY (US) 2006-09-12 US claimed
US-20040220378-A1 Compositions for golf equipment JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2004-11-04 US claimed
US-6369248-B1 HYDROXY ESTERS FOR PERFUMES GIVAUDAN SA (CH) 2002-04-09 US claimed
EP-0989970-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 2000-04-05 EP claimed
EP-0980863-A1 Oxime carboxylic acid derivatives Givaudan Roure (International) S.A. (CH) 2000-02-23 EP claimed
WO-1998058899-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-12-30 WO claimed
US-20250270438-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES CHAMPIONX LLC (US) 2025-08-28 US disclosed
EP-0887336-A1 Precursor Compounds GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) 1998-12-30 EP disclosed
EP-0887335-A1 Precursor compounds GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270438-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES HDHD5, HACL2, ADH5 PRKCA 4271/4885SIRT2 1686/4885ALOX5 104/4885
US-20220363976-A1 ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES HDHD5, HACL2, ADH5 PRKCA 4271/4885SIRT2 1686/4885ALOX5 104/4885
US-20240173230-A1 FRAGRANCE COMPOSITION FABP2, FABP5, FAAH2 PRKCA 4564/4885SIRT2 2315/4885ALOX5 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.